| 29-Sep-12 |
| Venmax Drugs and Pharmaceuticals Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 27, 2012 to September 29, 2012 (both days inclusive) for the purpose of 23rd Annual General Meeting (AGM) of the Company to be held on September 29, 2012.
Venmax Drugs and Pharmaceuticals Ltd has informed BSE that the 23rd Annual General Meeting (AGM) of the Company was held on September 29, 2012.
(As per BSE Announcement Dated on 05.10.2012)
|
| 30-Dec-11 |
| Venmax Drugs and Pharmaceuticals Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from December 28, 2011 to December 30, 2011 (both days inclusive) for the purpose of 22nd Annual General Meeting (AGM) of the Company to be held on December 30, 2011.
Venmax Drugs and Pharmaceuticals Ltd has informed BSE that the 22nd Annual General Meeting (AGM) of the Company was held on December 30, 2011.
1. Adopted the audited accounts for the year
ended March 31, 2011 together with the reports of the auditors and Directors.
2. Re-appointed Sri. Ramakrishaniah Appanaboyana, as a director liable for retirement by rotation.
3. Appointed M/s. Jawahar & Associates, Chartered
Accountants, as Auditors of the Company to hold office until the conclusion of the next Annual General Meeting on remuneration, terms & conditions.
(As Per BSE Announcement Website Dated on 03/01/2012) |
| 30-Dec-10 |
| AGM 30/12/2010
(Revised)
Venmax Drugs and Pharmaceuticals Ltd has informed BSE that the members at the 21st Annual General Meeting (AGM) of the Company held on December 30, 2010, inter alia, have taken the following decisions:
1. Adoption of audited accounts, reports
of auditors and director for the year 2009-2010.
2. Appointed a director in place of G. Gopal Yadav, who retires by rotation and being eligible offers himself for reappointment.
3. Appointed M/s. Jawahar and Associates as auditors of the Company.
4. Appointed Mrs. Hansa Vijay Jogadia as additional director of the Company.
(As Per BSE Announcement Dated on 30.12.2010) |
| 30-Sep-09 |
| AGM 30/09/2009
Yenkey Drugs & Pharmaceuticals Ltd has informed BSE that the members at the 20th Annual General Meeting (AGM) of the Company held on September 30, 2009, inter alia, have accorded to the following:
1. Adopted the audited accounts for the year ended March 31, 2009, together with the reports of the Auditors and Directors.
2. Appointment of M/s. Jawahar & Associates, Chartered Accountants, as Auditors of the Company to hold office for the period from the conclusion of this Meeting until the conclusion of the next Annual General Meeting of the Company, on remuneration terms & conditions.
3. Appointment of Sri. Nitesh Vijay Vargiya, Dr. A. Ramakrishnaiah & Sri. I. Seshagiri Rao as Directors of the Company, liable to retire by rotation.
4. Appointment of Ms. M. Usha Rani as Technical Director for a period of 1 year w.e.f. September 05, 2009, on remuneration, terms & conditions.
(As Per BSE Announcement Dated on 06/10/2009)
With reference to earlier annoucement regarding Outcome of AGM, Yenkey Drugs & Pharmaceuticals Ltd has informed BSE that in the said annoucement the Company had inadvertently communicated the outcome on item No 7, regarding renewal of appointment of Ms. Usha Rani as Technical Director and payment of remuneration and Prerequisites, as unanimously approved by the shareholders.
Actually the same Motion was defeated and hence the subject matter of the Motion Viz. renewal of appointment of Ms. Usha Rani as Technical Director and payment of remuneration and Perquisites was DEFEATED.
(As Per BSE Announcement Dated on 09/11/2009) |
| 29-Dec-08 |
| AGM 29/12/2008
Yenkey Drugs & Pharmaceuticals Ltd has informed BSE that the members at the Annual General Meeting (AGM) of the Company held on December 29, 2008, inter alia, have accorded to the following:
1. Adopted the audited accounts for the year-ended March 31, 2008, together with the reports of the Auditors and Directors.
2. Appointed a Director in place of G Gopal Yadav, & M Usha Rani, who retire by rotation and being eligible, offers themselves for re-election.
3. Appointed M/s. Jawahar and Associates, Hyderabad as Auditors of the Company.
5. Changed the name of the Company from "Yenkey Drugs & Pharmaceuticals Ltd" to "Venmax Drugs Pharmaceuticals Ltd".
6. The Company's paid up capital as on March 31, 2006 is Rs 463.53 lakhs divided into 46,35,300 shares of Rs 10/- each has been reduced to Rs 231.765 lakhs divided into 23,17,650 shares of Rs 10/- each as per the Hon'ble BIFR orders dated January 29, 2008.
Further the Company has informed that, the Company has got extension under Section 166(1) of the Companies Act, 1956 the Registrar of Companies, Andhra Pradesh has considered a period of 90 days to convene the Annual General Meeting.
(As Per BSE Announcement Website dated on 29.12.2008) |